European countries’ reforms have lost momentum, or even slipped backwards. Most drug-policy experts consider this a shame. The reformist countries’ experiences not only show how well liberal drug policies work; they suggest they need to go further. One of the problems is complacency – meaning that politicians in countries with harm-reduction policies often think the drug problem has been solved. In Europe “everyone is keeping each other in check,” says Tom Blickman. Europe is no longer a place where policymakers can take risks.